Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Incidence, prevalence and risk factors for hepatitis C in Danish prisons.

Søholm J, Holm DK, Mössner B, Madsen LW, Hansen JF, Weis N, Sauer AP, Awad T, Christensen PB.

PLoS One. 2019 Jul 26;14(7):e0220297. doi: 10.1371/journal.pone.0220297. eCollection 2019.

2.

Botulinum toxin treatment of spasticity targeted to muscle endplates: an international, randomised, evaluator-blinded study comparing two different botulinum toxin injection strategies for the treatment of upper limb spasticity.

Rekand T, Biering-Sörensen B, He J, Vilholm OJ, Christensen PB, Ulfarsson T, Belusa R, Ström T, Myrenfors P, Maisonobe P, Dalager T.

BMJ Open. 2019 May 5;9(5):e024340. doi: 10.1136/bmjopen-2018-024340.

3.

Combining liver stiffness with hyaluronic acid provides superior prognostic performance in chronic hepatitis C.

Hansen JF, Christiansen KM, Staugaard B, Moessner BK, Lillevang S, Krag A, Christensen PB.

PLoS One. 2019 Feb 11;14(2):e0212036. doi: 10.1371/journal.pone.0212036. eCollection 2019.

4.

Outcome and adverse events in patients with chronic hepatitis C treated with direct-acting antivirals: a clinical randomized study.

Sølund C, Andersen ES, Mössner B, Laursen AL, Røge BT, Kjær MS, Gerstoft J, Christensen PB, Pedersen MS, Schønning K, Fahnøe U, Bukh J, Weis N.

Eur J Gastroenterol Hepatol. 2018 Oct;30(10):1177-1186. doi: 10.1097/MEG.0000000000001192.

PMID:
29994874
5.

Direct acting antiviral treatment of chronic hepatitis C in Denmark: factors associated with and barriers to treatment initiation.

Sølund C, Hallager S, Pedersen MS, Fahnøe U, Ernst A, Krarup HB, Røge BT, Christensen PB, Laursen AL, Gerstoft J, Bélard E, Madsen LG, Schønning K, Pedersen AG, Bukh J, Weis N; DANHEP group.

Scand J Gastroenterol. 2018 Jun - Jul;53(7):849-856. doi: 10.1080/00365521.2018.1467963. Epub 2018 May 2.

PMID:
29720023
6.

[Controlled attenuation parameter is a novel technique in screening for non-alcoholic fatty liver disease].

Søholm J, Thiele MS, Christensen PB.

Ugeskr Laeger. 2018 Jan 29;180(5). pii: V05170414. Review. Danish.

PMID:
29393027
7.

Four weeks of ledipasvir/sofosbuvir and ribavirin with or without pegylated interferon for chronic hepatitis C in non-cirrhotic people who inject drugs. A randomized trial.

Øvrehus ALH, Krarup H, Birkemose I, Holm DK, Mössner B, Ernst A, Christensen PB.

J Hepatol. 2018 Apr;68(4):840-842. doi: 10.1016/j.jhep.2017.11.031. Epub 2017 Dec 7. No abstract available.

PMID:
29223370
8.

Liver-related morbidity and mortality in patients with chronic hepatitis C and cirrhosis with and without sustained virologic response.

Hallager S, Ladelund S, Christensen PB, Kjær M, Thorup Roege B, Grønbæk KE, Belard E, Barfod TS, Madsen LG, Gerstoft J, Tarp B, Krarup HB, Weis N.

Clin Epidemiol. 2017 Oct 24;9:501-516. doi: 10.2147/CLEP.S132072. eCollection 2017.

9.

Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark: A nationwide cohort study.

Hallager S, Ladelund S, Kjaer M, Madsen LG, Belard E, Laursen AL, Gerstoft J, Røge BT, Grønbaek KE, Krarup HB, Christensen PB, Weis N.

J Viral Hepat. 2018 Jan;25(1):47-55. doi: 10.1111/jvh.12764. Epub 2017 Sep 22.

PMID:
28750141
10.

Climate change stimulates the growth of the intertidal macroalgae Ascophyllum nodosum near the northern distribution limit.

Marbà N, Krause-Jensen D, Olesen B, Christensen PB, Merzouk A, Rodrigues J, Wegeberg S, Wilce RT.

Ambio. 2017 Feb;46(Suppl 1):119-131. doi: 10.1007/s13280-016-0873-7.

11.

Dried blood spots, valid screening for viral hepatitis and human immunodeficiency virus in real-life.

Mössner BK, Staugaard B, Jensen J, Lillevang ST, Christensen PB, Holm DK.

World J Gastroenterol. 2016 Sep 7;22(33):7604-12. doi: 10.3748/wjg.v22.i33.7604.

12.

Feasibility of transient elastography versus real-time two-dimensional shear wave elastography in difficult-to-scan patients.

Staugaard B, Christensen PB, Mössner B, Hansen JF, Madsen BS, Søholm J, Krag A, Thiele M.

Scand J Gastroenterol. 2016 Nov;51(11):1354-9. doi: 10.1080/00365521.2016.1193217. Epub 2016 Jun 16.

PMID:
27310486
13.

Involvement of distal sensory nerves in amyotrophic lateral sclerosis.

Isak B, Tankisi H, Johnsen B, Pugdahl K, Torvin MØLler A, Finnerup NB, Christensen PB, Fuglsang-Frederiksen A.

Muscle Nerve. 2016 Dec;54(6):1086-1092. doi: 10.1002/mus.25157. Epub 2016 Oct 7.

PMID:
27104485
14.

Liver mortality attributable to chronic hepatitis C virus infection in Denmark and Scotland--using spontaneous resolvers as the benchmark comparator.

Innes H, Hutchinson SJ, Obel N, Christensen PB, Aspinall EJ, Goldberg D, Krarup H, McDonald SA, McLeod A, Weir A, Omland LH.

Hepatology. 2016 May;63(5):1506-16. doi: 10.1002/hep.28458. Epub 2016 Mar 19.

PMID:
26773546
15.

[Liver fibrosis can be assessed by non-invasive ultrasound elastography].

Thielsen P, Wilkens R, Rafaelsen SR, Christensen PB.

Ugeskr Laeger. 2015 Jun 8;177(24):1155-8. Review. Danish.

PMID:
26554053
16.

Microfibrillar-Associated Protein 4: A Potential Biomarker for Screening for Liver Fibrosis in a Mixed Patient Cohort.

Sækmose SG, Mössner B, Christensen PB, Lindvig K, Schlosser A, Holst R, Barington T, Holmskov U, Sorensen GL.

PLoS One. 2015 Oct 13;10(10):e0140418. doi: 10.1371/journal.pone.0140418. eCollection 2015.

17.

Debilitating fatigue as a treatment indication in chronic hepatitis C.

Hjerrild S, Dalgard O, Christensen PB, Leutscher P.

J Hepatol. 2015 Dec;63(6):1533-4. doi: 10.1016/j.jhep.2015.08.003. Epub 2015 Aug 8. No abstract available.

PMID:
26264934
18.

Declining prevalence of hepatitis E antibodies among Danish blood donors.

Holm DK, Moessner BK, Engle RE, Zaaijer HL, Georgsen J, Purcell RH, Christensen PB.

Transfusion. 2015 Jul;55(7):1662-7. doi: 10.1111/trf.13028. Epub 2015 Mar 27.

PMID:
25819381
19.

Risk of all-type cancer, hepatocellular carcinoma, non-Hodgkin lymphoma and pancreatic cancer in patients infected with hepatitis B virus.

Andersen ES, Omland LH, Jepsen P, Krarup H, Christensen PB, Obel N, Weis N; DANVIR Cohort Study.

J Viral Hepat. 2015 Oct;22(10):828-34. doi: 10.1111/jvh.12391. Epub 2015 Feb 4.

PMID:
25650146
20.

Genetic variants in the apoptosis gene BCL2L1 improve response to interferon-based treatment of hepatitis C virus genotype 3 infection.

Clausen LN, Weis N, Ladelund S, Madsen L, Lunding S, Tarp B, Christensen PB, Krarup HB, Møller A, Gerstoft J, Clausen MR, Benfield T; DANHEP group.

Int J Mol Sci. 2015 Feb 2;16(2):3213-25. doi: 10.3390/ijms16023213.

21.

Influence of hepatitis C virus and IL28B genotypes on liver stiffness.

Lundbo LF, Clausen LN, Weis N, Schønning K, Rosenørn L, Benfield T, Christensen PB.

PLoS One. 2014 Dec 29;9(12):e115882. doi: 10.1371/journal.pone.0115882. eCollection 2014.

22.

Nationwide experience of treatment with protease inhibitors in chronic hepatitis C patients in Denmark: identification of viral resistance mutations.

Sølund C, Krarup H, Ramirez S, Thielsen P, Røge BT, Lunding S, Barfod TS, Madsen LG, Tarp B, Christensen PB, Gerstoft J, Laursen AL, Bukh J, Weis N; DANHEP group.

PLoS One. 2014 Dec 1;9(12):e113034. doi: 10.1371/journal.pone.0113034. eCollection 2014.

23.

Liver stiffness measurement among patients with chronic hepatitis B and C: results from a 5-year prospective study.

Christiansen KM, Mössner BK, Hansen JF, Jarnbjer EF, Pedersen C, Christensen PB.

PLoS One. 2014 Nov 4;9(11):e111912. doi: 10.1371/journal.pone.0111912. eCollection 2014.

24.

[Liver fibrosis can be assessed by non-invasive ultrasound elastography].

Thielsen P, Wilkens R, Rafaelsen SR, Christensen PB.

Ugeskr Laeger. 2014 Apr 7;176(15). pii: V11130694. Review. Danish.

PMID:
25350141
25.

Første orale hepatitis C-behandling er markedsført.

Christensen PB, Weis N, Laursen AL.

Ugeskr Laeger. 2014 Jun 2;176(11A). pii: V66248. Danish. No abstract available.

PMID:
25186702
26.

No transmission of blood-borne viruses among hospital staff despite frequent blood exposure.

Eskandarani HA, Kehrer M, Christensen PB.

Dan Med J. 2014 Sep;61(9):A4907.

PMID:
25186545
27.

Depressive symptoms are frequent among drug users, but not associated with hepatitis C infection.

Madsen LW, Fabricius T, Hjerrild S, Hansen TM, Mössner BK, Birkemose I, Skamling M, Christensen PB.

Scand J Infect Dis. 2014 Aug;46(8):566-72. doi: 10.3109/00365548.2014.918274. Epub 2014 Jun 16.

PMID:
24934987
28.

Review article: the efficacy of biomarkers in chronic fibroproliferative diseases - early diagnosis and prognosis, with liver fibrosis as an exemplar.

Karsdal MA, Krarup H, Sand JM, Christensen PB, Gerstoft J, Leeming DJ, Weis N, Schaffalitzky de Muckadell OB, Krag A.

Aliment Pharmacol Ther. 2014 Aug;40(3):233-49. doi: 10.1111/apt.12820. Epub 2014 Jun 9. Review.

29.

Strategies to manage hepatitis C virus (HCV) disease burden.

Wedemeyer H, Duberg AS, Buti M, Rosenberg WM, Frankova S, Esmat G, Örmeci N, Van Vlierberghe H, Gschwantler M, Akarca U, Aleman S, Balık I, Berg T, Bihl F, Bilodeau M, Blasco AJ, Brandão Mello CE, Bruggmann P, Calinas F, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cornberg M, Cramp ME, Dore GJ, Doss W, El-Sayed MH, Ergör G, Estes C, Falconer K, Félix J, Ferraz ML, Ferreira PR, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Guimarães Pessôa M, Hézode C, Hindman SJ, Hofer H, Husa P, Idilman R, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marinho RT, Marotta P, Mauss S, Mendes Correa MC, Moreno C, Müllhaupt B, Myers RP, Nemecek V, Øvrehus AL, Parkes J, Peltekian KM, Ramji A, Razavi H, Reis N, Roberts SK, Roudot-Thoraval F, Ryder SD, Sarmento-Castro R, Sarrazin C, Semela D, Sherman M, Shiha GE, Sperl J, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, Van Damme P, van Thiel I, Vandijck D, Vogel W, Waked I, Weis N, Wiegand J, Yosry A, Zekry A, Negro F, Sievert W, Gower E.

J Viral Hepat. 2014 May;21 Suppl 1:60-89. doi: 10.1111/jvh.12249.

PMID:
24713006
30.

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.

Razavi H, Waked I, Sarrazin C, Myers RP, Idilman R, Calinas F, Vogel W, Mendes Correa MC, Hézode C, Lázaro P, Akarca U, Aleman S, Balık I, Berg T, Bihl F, Bilodeau M, Blasco AJ, Brandão Mello CE, Bruggmann P, Buti M, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cramp ME, Dore GJ, Doss W, Duberg AS, El-Sayed MH, Ergör G, Esmat G, Falconer K, Félix J, Ferraz ML, Ferreira PR, Frankova S, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Gower E, Gschwantler M, Guimarães Pessôa M, Hindman SJ, Hofer H, Husa P, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Marinho RT, Marotta P, Mauss S, Moreno C, Murphy K, Negro F, Nemecek V, Örmeci N, Øvrehus AL, Parkes J, Pasini K, Peltekian KM, Ramji A, Reis N, Roberts SK, Rosenberg WM, Roudot-Thoraval F, Ryder SD, Sarmento-Castro R, Semela D, Sherman M, Shiha GE, Sievert W, Sperl J, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, Van Damme P, van Thiel I, Van Vlierberghe H, Vandijck D, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Cornberg M, Müllhaupt B, Estes C.

J Viral Hepat. 2014 May;21 Suppl 1:34-59. doi: 10.1111/jvh.12248.

PMID:
24713005
31.

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

Bruggmann P, Berg T, Øvrehus AL, Moreno C, Brandão Mello CE, Roudot-Thoraval F, Marinho RT, Sherman M, Ryder SD, Sperl J, Akarca U, Balık I, Bihl F, Bilodeau M, Blasco AJ, Buti M, Calinas F, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cornberg M, Cramp ME, Dore GJ, Doss W, Duberg AS, El-Sayed MH, Ergör G, Esmat G, Estes C, Falconer K, Félix J, Ferraz ML, Ferreira PR, Frankova S, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Gower E, Gschwantler M, Guimarães Pessôa M, Hézode C, Hofer H, Husa P, Idilman R, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marotta P, Mauss S, Mendes Correa MC, Müllhaupt B, Myers RP, Negro F, Nemecek V, Örmeci N, Parkes J, Peltekian KM, Ramji A, Razavi H, Reis N, Roberts SK, Rosenberg WM, Sarmento-Castro R, Sarrazin C, Semela D, Shiha GE, Sievert W, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, van Thiel I, Van Vlierberghe H, Vandijck D, Vogel W, Waked I, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Van Damme P, Aleman S, Hindman SJ.

J Viral Hepat. 2014 May;21 Suppl 1:5-33. doi: 10.1111/jvh.12247. Review.

PMID:
24713004
32.

Reply: To PMID 24519039.

Lagging M, Rembeck K, Waldenström J, Nilsson S, Nyström K, Martner A, Lindh M, Norkrans G, Westin J, Pedersen C, Färkkilä M, Langeland N, Buhl MR, Mørch K, Christensen PB, Hellstrand K.

Hepatology. 2014 Dec;60(6):2130-1. doi: 10.1002/hep.27108. Epub 2014 Sep 24. No abstract available.

PMID:
24591101
33.

Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3.

Rembeck K, Waldenström J, Hellstrand K, Nilsson S, Nyström K, Martner A, Lindh M, Norkrans G, Westin J, Pedersen C, Färkkilä M, Langeland N, Buhl MR, Mørch K, Christensen PB, Lagging M.

Hepatology. 2014 Jun;59(6):2131-9. doi: 10.1002/hep.27009. Epub 2014 Apr 25.

PMID:
24519039
34.

Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study.

Andersen ES, Rødgaard-Hansen S, Moessner B, Christensen PB, Møller HJ, Weis N.

Eur J Clin Microbiol Infect Dis. 2014 Jan;33(1):117-22. doi: 10.1007/s10096-013-1936-3. Epub 2013 Aug 10.

PMID:
24424890
35.

Socioeconomic status in HCV infected patients - risk and prognosis.

Omland LH, Osler M, Jepsen P, Krarup H, Weis N, Christensen PB, Roed C, Sørensen HT, Obel N.

Clin Epidemiol. 2013 May 31;5:163-72. doi: 10.2147/CLEP.S43926. Print 2013.

36.

Neutralizing antibodies in patients with chronic hepatitis C, genotype 1, against a panel of genotype 1 culture viruses: lack of correlation to treatment outcome.

Pedersen J, Jensen TB, Carlsen TH, Schønning K, Christensen PB, Laursen AL, Krarup H, Bukh J, Weis N.

PLoS One. 2013 May 7;8(5):e62674. doi: 10.1371/journal.pone.0062674. Print 2013.

37.

Upper motor neuron involvement in amyotrophic lateral sclerosis evaluated by triple stimulation technique and diffusion tensor MRI.

Furtula J, Johnsen B, Frandsen J, Rodell A, Christensen PB, Pugdahl K, Fuglsang-Frederiksen A.

J Neurol. 2013 Jun;260(6):1535-44. doi: 10.1007/s00415-012-6824-8. Epub 2013 Jan 9.

PMID:
23299622
38.

MUNIX and incremental stimulation MUNE in ALS patients and control subjects.

Furtula J, Johnsen B, Christensen PB, Pugdahl K, Bisgaard C, Christensen MK, Arentsen J, Frydenberg M, Fuglsang-Frederiksen A.

Clin Neurophysiol. 2013 Mar;124(3):610-8. doi: 10.1016/j.clinph.2012.08.023. Epub 2012 Oct 4.

PMID:
23040293
39.

IP-10 can be measured in dried plasma spots in patients with chronic hepatitis C infection.

Ruhwald M, Andersen ES, Christensen PB, Moessner BK, Weis N.

PLoS One. 2012;7(9):e45181. Epub 2012 Sep 14.

40.

Seasonal sea ice cover as principal driver of spatial and temporal variation in depth extension and annual production of kelp in Greenland.

Krause-Jensen D, Marbà N, Olesen B, Sejr MK, Christensen PB, Rodrigues J, Renaud PE, Balsby TJS, Rysgaard S.

Glob Chang Biol. 2012 Oct;18(10):2981-2994. doi: 10.1111/j.1365-2486.2012.02765.x. Epub 2012 Jul 26.

41.

PNPLA 3 I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection.

Rembeck K, Maglio C, Lagging M, Christensen PB, Färkkilä M, Langeland N, Buhl MR, Pedersen C, Mørch K, Norkrans G, Hellstrand K, Lindh M, Pirazzi C, Burza MA, Romeo S, Westin J; NORDynamIC group.

BMC Med Genet. 2012 Sep 14;13:82. doi: 10.1186/1471-2350-13-82.

42.

Hepatitis C prevalence in Denmark -an estimate based on multiple national registers.

Christensen PB, Hay G, Jepsen P, Omland LH, Just SA, Krarup HB, Weis N, Obel N, Cowan S.

BMC Infect Dis. 2012 Aug 6;12:178.

43.

Treatment for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection - Danish national guidelines 2011.

Christensen PB, Clausen MR, Krarup H, Laursen AL, Schlichting P, Weis N; Danish Society of Infectious Diseases; Danish Society of Gastroenterology and Hepatology.

Dan Med J. 2012 Jun;59(6):C4465.

PMID:
22677253
44.

Negative HCV-RNA 2 weeks after initiation of treatment predicts sustained virological response to pegylated interferon alfa-2a and ribavirin in patients with chronic hepatitis C.

Christensen PB, Krarup HB, Laursen AL, Madsen PH, Pedersen C, Schlichting P, Orholm M, Ring-Larsen H, Bukh J, Krogsgaard K.

Scand J Gastroenterol. 2012 Sep;47(8-9):1115-9. doi: 10.3109/00365521.2012.694905. Epub 2012 Jun 7.

PMID:
22670704
45.

Impact of obesity on the bioavailability of peginterferon-α2a and ribavirin and treatment outcome for chronic hepatitis C genotype 2 or 3.

Alsiö Å, Rembeck K, Askarieh G, Christensen PB, Färkkilä M, Langeland N, Buhl MR, Pedersen C, Mørch K, Haagmans BL, Nasic S, Westin J, Hellstrand K, Norkrans G, Lagging M.

PLoS One. 2012;7(5):e37521. doi: 10.1371/journal.pone.0037521. Epub 2012 May 24.

46.

Novel TARDBP mutations in Nordic ALS patients.

Chiang HH, Andersen PM, Tysnes OB, Gredal O, Christensen PB, Graff C.

J Hum Genet. 2012 May;57(5):316-9. doi: 10.1038/jhg.2012.24. Epub 2012 Mar 29.

PMID:
22456481
47.

Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3.

Rembeck K, Alsiö A, Christensen PB, Färkkilä M, Langeland N, Buhl MR, Pedersen C, Mørch K, Westin J, Lindh M, Hellstrand K, Norkrans G, Lagging M.

PLoS One. 2012;7(1):e29370. doi: 10.1371/journal.pone.0029370. Epub 2012 Jan 13.

48.

Universal screening for hepatitis B among pregnant women led to 96% vaccination coverage among newborns of HBsAg positive mothers in Denmark.

Harder KM, Cowan S, Eriksen MB, Krarup HB, Christensen PB.

Vaccine. 2011 Nov 21;29(50):9303-7. doi: 10.1016/j.vaccine.2011.10.028. Epub 2011 Oct 19.

PMID:
22019756
49.

HBeAg and not genotypes predicts viral load in patients with hepatitis B in Denmark: a nationwide cohort study.

Krarup H, Andersen S, Madsen PH, Christensen PB, Laursen AL, Bentzen-Petersen A, Møller JM, Weis N; DANHEP group.

Scand J Gastroenterol. 2011 Dec;46(12):1484-91. doi: 10.3109/00365521.2011.619273. Epub 2011 Sep 29.

PMID:
21958304
50.

Long-term follow-up among Danish transfusion recipients identified in the national hepatitis C lookback.

Just SA, Grau K, Georgsen J, Weis N, Cowan S, Groenbaek K, Krarup H, Christensen PB; Danish HCV Lookback Group.

Transfusion. 2012 Mar;52(3):582-8. doi: 10.1111/j.1537-2995.2011.03309.x. Epub 2011 Aug 29.

PMID:
21883266

Supplemental Content

Loading ...
Support Center